Rubicon Research

Last updated

Rubicon Research Pvt. Ltd.
Company type Private Limited company
Industry Pharmaceutical
Founded1999;25 years ago (1999)
Mumbai, India
Headquarters
Mumbai, India
,
India
Products Pharmaceuticals
ServicesContract Research, Formulation Development (NDDS), Contract Manufacturing & supply chain, Dossier Development ANDA/CTD format
Number of employees
200 (2010)
Website https://www.rubicon.co.in/

Rubicon Research is an IP led, specialty pharmaceutical company located in Mumbai, India. Its formulation development is across multiple dosage forms, oral solids, oral liquids, nasal, ophthalmic, topical, injectable, fixed dose combinations, and drug device combinations. In 2019 the company received USD 100 million in growth capital investment from General Atlantic, a growth equity firm. [1]

Contents

The company operates out of four locations. The corporate HQ and R&D center is in Thane, India. There's also an R&D center in Concord, Canada, a manufacturing plant located in Ambernath, India, and a regulatory office in Plainsboro, US.

History and Evolution

Rubicon Research was founded in 1999 by Pratibha Pilgaonkar, Sudhir Pilgaonkar, and Maharukh Rustomjee. In 2000 it started operations as an independent product development company, located in Bhandup, Mumbai, with three scientists in a 2,000 sq ft (190 m2) laboratory. It became an outsourcing partner to the global healthcare and pharmaceutical industry. In 2003, the Directorate of Science and Technology, Government of India approved the facilities as a commercial Research and Development (R&D) company.

In 2006-07 Rubicon licensed its Orodispersible excipient, RubiODT to Mallinckrodt Baker, Inc. [2]

In 2009 the company commission an oral solids manufacturing plant in Ambernath, India. The 140,000+ square feet cGM production facility is compliant with US FDA and EU specifications. Rubicon Research started its commercial manufacturing and shipments to the US and Europe in 2015. Rubicon Research was audited by USFDA in March 2015 & Dec 2015, both time they had Zero 483.

In 2012 Rubicon Research signed an agreement with Avantor Performance Materials to develop and market a novel gastro-retentive excipient that enables the delivery of molecules with a window of absorption. [3] [4]

In 2016, in Series B funding, the private equity firm Everstone Capital Asia bought out the stakes of Kotak Private Equity and Maharukh Rustomjee. [5] [6]

In 2019, Rubicon Research received a USD 100 million growth capital commitment from General Atlantic [7] [8] and acquired 15 ANDAs to augment its generic portfolio. [9] [10]

In 2020 Rubicon Research Private Limited acquired Impopharma Canada Limited with operations in Ontario, Canada, expanding its global development network, and established Rubicon Research Canada Ltd. [11] [12] The Canadian development facility specializes in the development and testing of pulmonary and nasal drug delivery systems and ophthalmic, otic, and dermal products.

In 2021 the company launched two subsidiaries—Rubicon Consumer Healthcare and Rubicon Academy. Rubicon Consumer Healthcare develops personal wellness, healthcare, and nutrition products for the Indian market. Rubicon Academy [13] is a learning platform for pharmaceutical professionals and students.

In July 2021, Rubicon Research announced the acquisition of Meditab Specialities Limited’s oral liquid dosage and nasal product manufacturing facility located in Satara, Maharashtra. [14] [15] [16] Meditab Specialities Limited is a wholly owned subsidiary of Cipla Limited. The Satara manufacturing facility is a state-of-the-art cGMP compliant and MHRA (UK) inspected production site. [17] [18]

Corporate structure

[19]

Related Research Articles

<span class="mw-page-title-main">Tablet (pharmacy)</span> Drug delivery form in which the ingredients are solidified for later consumption

A tablet is a pharmaceutical oral dosage form or solid unit dosage form. Tablets may be defined as the solid unit dosage form of medication with suitable excipients. It comprises a mixture of active substances and excipients, usually in powder form, that are pressed or compacted into a solid dose. The main advantages of tablets are that they ensure a consistent dose of medicine that is easy to consume.

<span class="mw-page-title-main">Cipla</span> Indian multinational pharmaceutical company

Cipla Limited is an Indian multinational pharmaceutical company headquartered in Mumbai. Cipla primarily focuses on developing medication to treat respiratory disease, cardiovascular disease, arthritis, diabetes, depression, and various other medical conditions. Cipla has 47 manufacturing locations across the world and sells its products in 86 countries. It is the third-largest drug producer in India.

Dr. Reddy's Laboratories is an Indian multinational pharmaceutical company based in Hyderabad. The company was founded by Kallam Anji Reddy, who previously worked in the mentor institute Indian Drugs and Pharmaceuticals Limited. Dr. Reddy manufactures and markets a wide range of pharmaceuticals in India and overseas. The company produces over 190 medications, 60 active pharmaceutical ingredients (APIs) for drug manufacture, diagnostic kits, critical care, and biotechnology.

<span class="mw-page-title-main">Biocon</span> Indian multinational biopharmaceutical company

Biocon Limited is an Indian biopharmaceutical company based in Bangalore. It was founded by Kiran Mazumdar-Shaw in 1978. The company manufactures generic active pharmaceutical ingredients (APIs) that are sold in approximately 120 countries, including the United States and Europe. It also manufactures novel biologics as well as biosimilar insulins and antibodies, which are sold in India as branded formulations. Biocon's biosimilar products are also sold in both bulk and formulation forms in several emerging markets.

<span class="mw-page-title-main">VWR International</span> U.S. chemicals company

VWR International is an American company involved in the distribution of research laboratory products, with over 1,200,000 items to more than 250,000 customers in North America and Europe. The U.S. division is headquartered in Radnor, Pennsylvania. VWR ranked #91 in 2006, and #77 in 2005, in Forbes list of largest American private companies. Suppliers include Applied Scientific, 3B Scientific Duracell, Kimberly-Clark, Bel-Art Products, and Welch Allyn. VWR primarily serves the government, biotechnology, life science, education, electronics and pharmaceutical sectors. In 2010, the company maintained operations in 25 countries and processed approximately 50,000 order lines daily from a logistical network, which includes 25 strategically located distribution centers.

<span class="mw-page-title-main">Perrigo</span> Irish tax-registered pharmaceutical

Perrigo Company plc is an American Irish-registered manufacturer of private label over-the-counter pharmaceuticals, and while 70% of Perrigo's net sales are from the U.S. healthcare system, Perrigo is legally headquartered in Ireland for tax purposes, which accounts for 0.60% of net sales. In 2013, Perrigo completed the sixth-largest US corporate tax inversion in history when it reregistered its tax status to Ireland to avoid U.S. corporate taxes. Perrigo maintains its corporate headquarters in Grand Rapids, Michigan, within Michigan State University's Grand Rapids Innovation Park.

The pharmaceutical industry in India was valued at an estimated US$42 billion in 2021 and is estimated to reach $130 billion by 2030. India is the world's largest provider of generic medicines by volume, with a 20% share of total global pharmaceutical exports. It is also the largest vaccine supplier in the world by volume, accounting for more than 60% of all vaccines manufactured in the world. Indian pharmaceutical products are exported to various regulated markets including the US, UK, European Union and Canada.

Prestige Consumer Healthcare Inc. is an American company that markets and distributes over-the-counter healthcare and household cleaning products. It was formed by the merger of Medtech Products, Inc., Prestige Brands International, and the Spic and Span Company in 1996. The company is headquartered in Tarrytown, New York and operates a manufacturing facility in Lynchburg, Virginia.

Torrent Pharmaceuticals Ltd is an Indian multinational pharmaceutical company, part of the Torrent Group and headquartered in Ahmedabad. It was promoted by U. N. Mehta, initially as Trinity Laboratories Ltd, and was later renamed Torrent Pharmaceuticals Ltd.

<span class="mw-page-title-main">Zydus Lifesciences</span> Indian multinational pharmaceutical company

Zydus Lifesciences Limited, formerly known as Cadila Healthcare Limited, is an Indian multinational pharmaceutical company headquartered in Ahmedabad, which is primarily engaged in the manufacturing of generic drugs. The company ranked 100th in the Fortune India 500 list in 2020.

<span class="mw-page-title-main">Sun Pharma</span> Indian multinational pharmaceutical company

Sun Pharmaceutical Industries Limited is an Indian multinational pharmaceutical company headquartered in Mumbai, that manufactures and sells pharmaceutical formulations and active pharmaceutical ingredients (APIs) in more than 100 countries across the globe. It is the largest pharmaceutical company in India and the fourth largest specialty generic pharmaceutical company in the world. The products cater to a vast range of therapeutic segments covering psychiatry, anti-infectives, neurology, cardiology, diabetology, gastroenterology, ophthalmology, nephrology, urology, dermatology, gynecology, respiratory, oncology, dental and nutritionals. 

A contract manufacturing organization (CMO), more recently referred to as a contract development and manufacturing organization (CDMO) to avoid the acronym confusion of Chief Medical Officer or Clinical Monitoring Organization in the pharma industry, is a company that serves other companies in the pharmaceutical industry on a contract basis to provide comprehensive services from drug development through drug manufacturing. This allows major pharmaceutical companies to outsource those aspects of the business, which can help with scalability or can allow the major company to focus on drug discovery and drug marketing instead.

Granules India Limited is an Indian pharmaceutical manufacturing company based in Hyderabad, India. Granules manufactures several off-patent drugs, including Paracetamol, Ibuprofen, Metformin and Guaifenesin, on a large scale for customers in the regulated and rest of the world markets. Granules India Limited entered CRAMS segment, which focuses on contract research and manufacturing.

<span class="mw-page-title-main">Intas Pharmaceuticals</span> Indian multinational pharmaceutical company

Intas Pharmaceuticals Limited is an Indian multinational pharmaceutical company headquartered in Ahmedabad. It is a producer of generic therapeutic drugs and engaged in contract clinical research and manufacturing. It has 22 manufacturing plants, 17 in India and the rest in Greece, United Kingdom and Mexico. In the financial year 2019, 69% of the company's revenue came from international markets while 31% came from India. It's market presence is more than 100+ countries.

<span class="mw-page-title-main">Amneal Pharmaceuticals</span> American publicly traded generics and specialty pharmaceutical company

Amneal Pharmaceuticals, Inc. is an American publicly traded generics and specialty pharmaceutical company. The company is headquartered in Bridgewater, New Jersey.

<span class="mw-page-title-main">Piramal Group</span> Indian conglomerate

The Piramal Group is an Indian multinational conglomerate that has presence across various sectors such as healthcare, life sciences, drug discovery, financial services, alternative investment and real estate.

Francis Xavier Kitaka was a Ugandan biochemist, veterinarian, entrepreneur and industrialist. He is the former Chairman of Cipla Quality Chemical Industries Limited (CIPLAQCIL), located in Luzira, a suburb of Kampala, Uganda's capital and largest city. CIPLAQCIL is the only company in Sub-Saharan Africa, that is authorized to manufacture triple therapy antiretroviral drugs.

Biotechnology in India is a sunrise sector within the Indian economy. Agencies of the Government of India concerned with the biotechnology industry include the Department of Biotechnology and the proposed Biotechnology Regulatory Authority of India. As of 2022, the sector is valued at $80 billion. Biotechnology in India is in a growth phase and the sector is expected to be valued at $150 billion by 2025 and surpass $300 billion in value by 2030.

Dawa Life Sciences Company based in Nairobi, Kenya

Dawa Life Sciences is a Kenyan life sciences company with core competencies in healthcare. It was founded by Dr. Raju Mohindra and Dr. Ajay Patel in 1994. Dawa Life Sciences provides better medication for humans and animals. The company is based in Kenya and is structured to offer a wide range of products and support throughout the region and beyond.


Avantor is an American biotechnology, chemicals, and pharmaceuticals company headquartered in Radnor, Pennsylvania. The company ranked 484th on the 2020 Fortune 500, based on its 2019 sales.

References

  1. ↑ "General Atlantic acquires significant shareholding in Rubicon Research". The Financial Express. 9 April 2019. Retrieved 29 April 2021.
  2. ↑ Pharmaceutical online : Mallinckrodt Baker And Rubicon Research Sign Agreement For Performance Excipient Development
  3. ↑ "Avantor, Rubicon Research Collaborate on Functional Excipient Development". Drug Discovery and Development. 16 October 2012. Retrieved 29 April 2021.
  4. ↑ "Avantor and Rubicon Research to collaborate on novel excipients". www.manufacturingchemist.com. Retrieved 29 April 2021.
  5. ↑ "Everstone buys Mumbai-based drug tech firm Rubicon for Rs 220-crore". The Economic Times. Retrieved 12 May 2021.
  6. ↑ "Everstone buys majority stake in Rubicon Research; Kotak PE exits". VCCircle. 24 October 2016. Retrieved 12 May 2021.
  7. ↑ "Rubicon Research and General Atlantic Announce Strategic Partnership". General Atlantic. Retrieved 12 May 2021.
  8. ↑ Dhanjal, Swaraj Singh (8 April 2019). "General Atlantic to invest $100 million in Rubicon". mint. Retrieved 12 May 2021.
  9. ↑ "General Atlantic acquires significant shareholding in Rubicon Research". The Financial Express. 9 April 2019. Retrieved 12 May 2021.
  10. ↑ "Everstone scores one of its best exits as General Atlantic strikes a control deal". VCCircle. 1 April 2019. Retrieved 12 May 2021.
  11. ↑ "Rubicon Research Acquires Impopharma Canada". www.businesswire.com. 7 January 2020. Retrieved 12 May 2021.
  12. ↑ "Rubicon Research Acquires Impopharma Canada". financialpost. Retrieved 12 May 2021.
  13. ↑ "COVID-19 has made online learning a credible source of education". Express Pharma. 14 October 2020. Retrieved 12 May 2021.
  14. ↑ "Rubicon Research acquires Satara facility of Meditab Specialities". www.outlookindia.com/. Retrieved 24 August 2021.
  15. ↑ Livemint (9 July 2021). "General Atlantic-led Rubicon Research acquires Meditab Specialities". mint. Retrieved 24 August 2021.
  16. ↑ "Rubicon Research acquires Satara facility of Meditab Specialities". The Economic Times. Retrieved 24 August 2021.
  17. ↑ "Rubicon Research acquires MeditabSpecialities' facility in Satara, Maharashtra". Express Pharma. 9 July 2021. Retrieved 24 August 2021.
  18. ↑ "Rubicon Research acquires Cipla arm's oral liquid, nasal product unit". The Hindu. 9 July 2021. ISSN   0971-751X . Retrieved 24 August 2021.
  19. ↑ Bloomsberg Businessweek: Rubicon Research Private Limited
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.